Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1982; 48(03): 341
DOI: 10.1055/s-0038-1657296
DOI: 10.1055/s-0038-1657296
Letter to the Editor
Sex Difference in Circulating Platelet Aggregates and Response to Antiplatelet Treatment
Further Information
Publication History
Received 13 May 1982
Accepted 08 September 1982
Publication Date:
13 July 2018 (online)
-
References
- 1 Anturan Reinfarction Italian Study. Sulphinpyrazone in post-myocardial infarction. Lancet 1982; 1: 237-242
- 2 Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med 1977; 297: 1246-1249
- 3 The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-59
- 4 Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M. The role of sulfinpyrazone in the prevention of arteriovenous shunt thrombosis. Circulation 1975; 52: 497-499
- 5 Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2: 924-926
- 6 Kelton JG, Powers P, Julian J, Boland V, Carter CJ, Gent H, Hirsh J. Sex-related differences in platelet aggregation: influence of hematocrit. Blood 1980; 56: 38-41